A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/163
A61K 9/127 (2006.01) A61K 9/16 (2006.01)
Patent
CA 1338701
Methods and compositions are described for nonliposomal lipid complexes in association with toxic hydrophobic drugs such as the polyene antibiotic amphotericin B. Lipid compositions are preferably a combination of the phospholipids dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) in about a 7:3 mole ratio. The lipid complexes contain a bioactive agent and may be made by a number of procedures, at high drug:lipid ratios. These compositions of high drug:lipid complexes (HDLCs) may be administered to mammals such as humans for the treatment of infections, with substantially equivalent or greater efficacy and reduced drug toxicities as compared to the drugs in their free form. Also disclosed is a novel liposome-loading procedure, which may also be used in the formation of the HDLCs.
560121
Boni Lawrence
Cullis Pieter R.
Durning Anthony G.
Janoff Andrew S.
Kearns John J.
Defiante Farmaceutica S.a.
Osler Hoskin & Harcourt Llp
LandOfFree
Low toxicity drug-lipid systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low toxicity drug-lipid systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low toxicity drug-lipid systems will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1210843